Tag Archives: Trademarks
GSK to Buy BMS’s HIV Portfolio
Drug giant GlaxoSmithKline has reached a deal to acquire Bristol-Myers Squibb’s HIV portfolio. GSK will pay $350 million up front and could pay an additional $1 billion depending on developmental and sales milestones. GSK did the deal through its subsidiary … Continue reading
Bayer Loses CTM Opposition
On 29 October 2015, OHIM’s Opposition Division of the Office dismissed Bayer’s opposition against registration of the mark SALOSPIR & Design (No. 012351458). Bayer opposed Uni-Pharma SA’s application for the mark SALOSPIR & Design for pharmaceutical preparations in Class 5 based on three … Continue reading
McCarthy Against IP Centralization
In response to calls to centralize all trademark appeals to the Federal Circuit, leading trademark expert – literally, the man who wrote the book on trademarks – J. Thomas McCarthy (and Dina Roumiantseva), think not. With some regularity over the years, … Continue reading
Court Cancels URBAN HOMESTEADING Trademark
In a longstanding dispute between advocates of urban farming and the Dervaes family of Pasadena, a federal district judge gave opponents of the Dervaes’ a partial victory when he ordered cancellation of the trademark for URBAN HOMESTEADING on the grounds … Continue reading
B&B Hardware: TTAB decisions to have preclusive effect in trademark litigation (sometimes)
In B&B Hardware Inc. v. Hargis Industries, Inc. (Supreme Court 2015), the Supreme Court held that Trademark Trial and Appeal Board (TTAB) decisions regarding likelihood of confusion have preclusive effect in subsequent district court infringement actions “[s]o long as the … Continue reading
Madrid Protocol Tip: Calculating Office Action Deadlines
Don’t get tripped up when calculating the deadline within which to respond to an Office action issued in connection a Section 66(a) application at the U.S. Patent & Trademark Office. A response to an Office action issued by the USPTO … Continue reading